Florida Cancer Affiliates
Print Text Size
  • Home
  • About Us
  • Careers
  • Contact Us
  • Menu
  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers &
    Blood Diseases
  • Clinical Trials
    & Research
  • For Medical
    Professionals
  • Pharmacy
  • About Us
  • Careers
  • Contact Us

Medical News on Cancer

Physicians Have Trouble Stopping PSA Tests, Despite Questionable Benefits

May 29, 2012

Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators... Read More

When Should PSA Screening Stop? Doctors Cannot Agree

May 28, 2012

Prostate cancer is a slow-growing disease, and doctors are forever facing multiple barriers to discontinuing routine PSA screening. So, perhaps it is not surprising that consensus in the medical community on when to discontinue PSA screening is hard to achieve. Put simply, doctors are unable to agree completely when an old man should no longer be screened for prostate cancer... Read More

New Cancer Therapies Likely Following 'Orphan' Sleep Drug Findings

May 23, 2012

An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies... Read More

Sigmoidoscopy Reduces Colorectal Cancer Rates

May 23, 2012

Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health... Read More

Predicting Response To New Treatments In Colon Cancer

May 22, 2012

The Stem Cells and Cancer Research Group headed by Dr Hector G. Palmer at the Vall d'Hebron Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment... Read More

Cervical Cancer Patients Avoid Hysterectomies With Help Of 3-D Imaging Techniques

May 15, 2012

A study presented by Dr. Renaud Mazeron at the World Congress of Brachytherapy reveals that many cases of hysterectomy, as well as recurrence and spreading of cancer of the cervix can be controlled effectively by delivering radiotherapy directly to the cancer with 3-D imaging techniques... Read More

Hysterectomies May Be Avoided For Cervical Cancer Patients Using 3-D Image Guided Brachytherapy

May 11, 2012

Delivering radiotherapy directly to cancer of the cervix using 3-D imaging techniques is effective at controlling the return and spread of the disease and, in most cases, avoids the need for hysterectomies, according to research presented at the World Congress of Brachytherapy [1 & 2]... Read More

White And Affluent Women Fared Better Than African American And Poor Women In Ovarian Cancer Care And Survival

May 10, 2012

Poor women and African Americans with ovarian cancer are less likely to receive the highest standards of care, leading to worse outcomes than among white and affluent patients, according to a study of 50,000 women presented by UC Irvine's Dr. Robert Bristow at the Society of Gynecologic Oncology's annual meeting... Read More

The Mystery Of The Missing Breast Cancer Genes

May 09, 2012

Researchers from the University of Adelaide are hoping to better understand why the mutated genes for breast and ovarian cancer are not passed on more frequently from one generation of women to the next. That's despite a documented link between breast cancer genes and increased fertility in women... Read More

HPV Vaccine Completion Rate Among Girls Is Poor, Getting Worse

May 08, 2012

The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly - as much as 63 percent - since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston... Read More

Previous Page   Next Page

For Medical Professionals

  • Overview
  • Patient Forms
  • Industry News

The US Oncology Network

  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers
    & Blood Diseases
  • For Medical
    Professionals
  • Pharmacy
Florida Cancer Affiliates ©2025 All rights reserved. | Privacy Practices | Verbal Communications Form
Website by 30 Degrees North